Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
6,520.00
+110.00 (1.72%)
Nov 4, 2026, 3:30 PM KST
| Market Cap | 180.46B +76.5% |
| Revenue (ttm) | 108.14B +5.8% |
| Net Income | 1.41B |
| EPS | 60.34 |
| Shares Out | 27.68M |
| PE Ratio | 108.06 |
| Forward PE | n/a |
| Dividend | 30.00 (0.46%) |
| Ex-Dividend Date | Mar 3, 2026 |
| Volume | 2,581,155 |
| Open | 6,520.00 |
| Previous Close | 6,410.00 |
| Day's Range | 6,200.00 - 6,990.00 |
| 52-Week Range | 3,500.00 - 15,960.00 |
| Beta | 0.72 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |